With MRSA bacteraemia rates hovering around 1,000 cases per quarter (HPA report: April 2008) the need to prevent hospital acquired infection, in particular, catheter related bloodstream Infections, is greater than ever. This objective could be made easier with the launch of a new infection control product from PLIVA.
Using Ionic Silver as the active antimicrobial ensures clinical effectiveness for up to seven days without the problem of emerging resistance, a major factor when prescribing antimicrobials. Available in two sizes, Zonex is designed to cover a wide variety of medical devices – including IV cannula, PICCs, CVCs, epidural catheters and supra-pubic catheters.
